TY - JOUR
T1 - Halogenated analogs of 1′-acetoxychavicol acetate, Rev-export inhibitor from Alpinia galanga, designed from mechanism of action
AU - Tamura, Satoru
AU - Shiomi, Atsushi
AU - Kimura, Tominori
AU - Murakami, Nobutoshi
N1 - Funding Information:
We wish to thank Professor Minoru Yoshida in RIKEN Advanced Science Institute for giving the fission yeast S. pombe. This work was supported in part by Grants-in-Aid for Scientific Research (Grant No. 19590100 ) from the Ministry of Education, Science, Culture and Sports. The authors are grateful to the Shorai Foundation for Science and Technology for financial support.
PY - 2010/4/1
Y1 - 2010/4/1
N2 - In the course of search for the robust analogs of 1′-acetoxychavicol acetate (ACA, 1), the Rev-export inhibitor from the medicinal plant Alpinia galanga, we clarified formation of the quinone methide intermediate ii to be essential for exerting the inhibitory activity of 1. Based on this mechanism of action, the rational design from the MO calculation of the conclusive activation energy to ii resulted in the four halogenated analogs with more potent activity than ACA (1). In particular, the difluoroanalog 20d exhibited approximately four-fold potent activity as compared with 1.
AB - In the course of search for the robust analogs of 1′-acetoxychavicol acetate (ACA, 1), the Rev-export inhibitor from the medicinal plant Alpinia galanga, we clarified formation of the quinone methide intermediate ii to be essential for exerting the inhibitory activity of 1. Based on this mechanism of action, the rational design from the MO calculation of the conclusive activation energy to ii resulted in the four halogenated analogs with more potent activity than ACA (1). In particular, the difluoroanalog 20d exhibited approximately four-fold potent activity as compared with 1.
KW - 1′-Acetoxychavicol acetate
KW - Evidence-based design
KW - Halogenated analog
KW - Quinone methide
KW - Rev-export inhibitor
UR - http://www.scopus.com/inward/record.url?scp=77949491228&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77949491228&partnerID=8YFLogxK
U2 - 10.1016/j.bmcl.2010.02.070
DO - 10.1016/j.bmcl.2010.02.070
M3 - Article
C2 - 20219373
AN - SCOPUS:77949491228
SN - 0960-894X
VL - 20
SP - 2082
EP - 2085
JO - Bioorganic and Medicinal Chemistry Letters
JF - Bioorganic and Medicinal Chemistry Letters
IS - 7
ER -